老虎证券

美股详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Taro Pharmaceutical Industries L

42.97
0.0000
成交量：- -
成交额：- -
市值：16.15亿
市盈率：29.98
高：42.97
开：42.97
低：42.97
收：42.97
52周最高：42.97
52周最低：42.97
股本：3,758.46万
流通股本：808.59万
量比：- -
换手率：- -
股息：- -
股息率：- -
每股收益(TTM):1.43
每股收益(LYR):1.43
净资产收益率：3.06%
总资产收益率：0.21%
市净率：0.90
市盈率(LYR):29.98

数据加载中...

总览公司新闻资讯公告
2020/06/19

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/05/15

SEC问询函

CORRESP [Cover] - Correspondence
2020/04/10

SEC问询函

CORRESP [Cover] - Correspondence
2020/04/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/21

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/20

SEC问询函

CORRESP [Cover] - Correspondence
2020/02/07

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/23

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/23

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/17

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/03

SEC问询函

[Cover]Correspondence
2019/11/15

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/08

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/21

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
更多